Hyperspectral chemical imaging via sum-frequency generation microscopic holography
Project Number1R21EB034418-01A1
Former Number1R21EB034418-01
Contact PI/Project LeaderGE, NIEN-HUI
Awardee OrganizationUNIVERSITY OF CALIFORNIA-IRVINE
Description
Abstract Text
Project Summary: This proposal outlines a new investigator grant (NIBIB Trailblazer R21) for the PI to develop
a new holographic platform that enables high-speed, noninvasive 3D chemical imaging with broad biomedical
applications, including analysis of tumor microenvironment and real-time imaging of live cell cultures/animal
models/engineered tissues. While nonlinear optical microscopy is an attractive approach because it is label-free,
nondestructive, and offers higher resolution and richer information than linear microscopy, it usually involves 3D
scanning that limits the imaging refresh rate. To obviate this bottleneck, recent research has sought to combine
nonlinear optical microscopy with digital holography to vastly improve imaging speed. However, current
implementations either lack chemical selectivity or require tuning the laser wavelength in order to measure
vibrational spectra. To achieve a deeper understanding of biomedical processes at the molecular level, there is
clearly a significant need to further improve imaging speed and obtain rich spectral information. The long-term
goal is to develop a new nonlinear digital microscopic holography approach capable of high-speed 3D imaging
with spectroscopic vibrational contrast: i.e., 5D imaging in spatial, temporal, and spectral dimensions, in live cell
cultures and animal tissues. This transformational tool will enable discoveries of disease mechanisms and new
treatment paradigms. This application’s objective is to demonstrate the feasibility of a new approach to achieving
time-domain hyperspectral microscopic holography through vibrationally resonant (VR) sum-frequency
generation (SFG) and third-order sum-frequency generation (TSFG). Using mid-infrared photons to resonantly
excite vibrational modes will enable chemical mapping of different functional groups in specimens, while the
nonlinear processes offer submicron resolution. Combining SFG and TSFG in one instrument will enable
multimodal probing of non-centrosymmetric sample components as well as other components. Hyperspectral
holography will enable 3D imaging and simultaneous recovery of the signal field’s amplitude, phase, and spectral
frequency in a single time scan. Three specific aims will be pursued: Aim 1 is to demonstrate hyperspectral VR-SFG microscopic holography and validate its performance. Based on comparison to the phase-sensitive
multiplex VR-SFG microscopy previously demonstrated in the applicant’s hands, a single holographic
interferogram can be measured with a 4-μs exposure time and a signal-to-noise ratio of 10, with further
improvement in signal-to-noise ratio expected. Aim 2 is to demonstrate multimodal VR- SFG/TSFG and to
accelerate the acquisition rate by ~10x via compressive sensing. Aim 3 is to expand the spectral range to the
fingerprint region through building a new mid-infrared light source. The approach is innovative because it
integrates concepts in a new unproven format for imaging with unprecedented speed and vibrational
spectroscopic contrast. The proposed research is significant because it is expected to vertically advance
nonlinear digital microscopic holography for chemical mapping with submicron/subcellular resolutions.
Public Health Relevance Statement
Project Narrative:
Fast 3D imaging techniques are important for biomedical research and clinical diagnostics. This project seeks to
develop a new nonlinear digital microscopic holography approach that can reveal chemical signatures and
structural dynamics of biological specimens with unprecedented speeds. This transformational tool may provide
deep insight into open questions and enable discoveries of disease mechanisms and new treatment paradigms.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
046705849
UEI
MJC5FCYQTPE6
Project Start Date
01-August-2024
Project End Date
30-April-2027
Budget Start Date
01-August-2024
Budget End Date
30-April-2025
Project Funding Information for 2024
Total Funding
$224,104
Direct Costs
$150,000
Indirect Costs
$74,104
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$224,104
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21EB034418-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21EB034418-01A1
Patents
No Patents information available for 1R21EB034418-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21EB034418-01A1
Clinical Studies
No Clinical Studies information available for 1R21EB034418-01A1
News and More
Related News Releases
No news release information available for 1R21EB034418-01A1
History
No Historical information available for 1R21EB034418-01A1
Similar Projects
No Similar Projects information available for 1R21EB034418-01A1